The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Part of paid clinical trials in New York, New York.
- Sponsor
- The Rogosin Institute
- Study ID
- NCT01109368
- Status
- Recruiting
Conditions
- Homozygous Familial Hypercholesterolemia
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
This repository will establish for the first time a system to carefully assess and monitor over time the general health and the amount of cholesterol in the arteries of U.S. children and adults with homozygous familial hypercholesterolemia (hoFH). Patients with this very rare disorder have very high blood levels of cholesterol from birth due to the inheritance of an abnormal gene from each parent. As a result, if untreated, heart attacks and sudden death occur in childhood. Treatments such as LDL-apheresis and liver transplant will lower the cholesterol level, but the best treatment and the best way to monitor the effect of the treatment on the arteries are unknown. The collection of clinical data and blood for analysis of known and yet-to-be discovered markers and predictors of arterial disease will yield new information about the natural history of the disorder and response to treatment. The repository will greatly aid the development of specific protocols that seek to learn more about this disease and new therapies.
Key Dates
- Start date
- Jun 30, 2010
- Status verified
- Mar 2026
- Primary completion
- May 31, 2030
- Completion
- May 31, 2030
Study Design
- Enrollment
- 60 participants (estimated)
Primary Outcome Measure
Change in disease progression [ Time Frame: 10 years ]
Central Contacts
- Lisa C. Hudgins, M.D.(212) 746-3561
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Weill Cornell Medical College | New York | New York | 10021 | Lisa Hudgins, M.D. (PRINCIPAL_INVESTIGATOR) Daniel Levine, Ph.D. (SUB_INVESTIGATOR) Geoffrey Bergman, M.D. (SUB_INVESTIGATOR) Sheila Carroll, M.D. (SUB_INVESTIGATOR) Ajay Mirani, M.D. (SUB_INVESTIGATOR) Akiko Maehera, M.D. (SUB_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)PHASE3 · Recruiting · Arrowhead Pharmaceuticals · Park Ridge, Illinois
- HoFH, the International Clinical Collaborators RegistryRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania